In colorectal cancer, KLK8 facilitated the EMT processes which could be mitigated by protease-activated receptor antagonists, suggesting that the protease activity might be the mechanism by which KLK8 exerted its tumor-promoting functions [16]. The gene discussed is KLK8; the disease is neoplasm.